High-Fat Diet—Shared Environmental Risk Factor for Amyotrophic Lateral Sclerosis and Multiple Sclerosis
Sclerosis,
Journal Year:
2025,
Volume and Issue:
3(1), P. 1 - 1
Published: Jan. 12, 2025
Background:
Amyotrophic
lateral
sclerosis
(ALS)
and
multiple
(MS)
are,
in
essence,
neurodegenerative
disorders
with
significant
individual,
social,
economic
burdens
worldwide.
Despite
having
different
clinical
onset
evolution,
the
two
diseases
share
common
risk
factors
underlying
pathophysiological
mechanisms.
Environmental
are
particularly
interesting,
considering
available
effective
counter
strategies.
High-fat
diets
remain
a
element
that
negatively
impacts
evolution
of
several
disorders,
including
ALS
MS.
Focusing
on
changeable
disease-related
aspects
is
increasingly
appealing
context
lack
an
treatment.
Methods:
This
review
aims
to
offer
updated
overview
influence
high-fat
modulating
progression
MS,
based
search
three
relevant
online
databases.
Results:
In
first
part,
shared
mechanisms
MS
shown,
differences
between
highlighted.
Subsequently,
most
research
this
topic
conducted
animal
models
humans
presented,
bringing
additional
proof
critical
role
neurodegeneration.
Finally,
current
knowledge,
authors
potential
therapeutic
approaches
future
directions
better
control
nutrition
patients,
hoping
increase
survival
quality
life.
Conclusions:
impact
Language: Английский
Antioxidant Therapies in the Treatment of Multiple Sclerosis
Biomolecules,
Journal Year:
2024,
Volume and Issue:
14(10), P. 1266 - 1266
Published: Oct. 8, 2024
Several
studies
have
proposed
a
potential
role
for
oxidative
stress
in
the
development
of
multiple
sclerosis
(MS).
For
this
reason,
it
seems
tentative
to
think
that
treatment
with
antioxidant
substances
could
be
useful
disease.
In
narrative
review,
we
provide
summary
current
findings
on
treatments,
both
experimental
models
MS,
especially
autoimmune
encephalomyelitis
(EAE)
and
cuprizone-induced
demyelination
model,
clinical
trials
patients
diagnosed
MS.
Practically
all
antioxidants
tested
MS
shown
improvement
parameters,
delaying
evolution
disease,
improving
histological
biochemical
including
decreased
levels
markers
inflammation
central
nervous
system
other
tissues.
Only
few
been
carried
out
investigate
efficacy
most
them
short
term
involving
series
patients,
so
results
these
should
considered
inconclusive.
regard,
would
desirable
design
long-term,
randomized,
multicenter
long
assessing
several
demonstrated
Language: Английский
Protective Role of High-Density Lipoprotein in Multiple Sclerosis
Antioxidants,
Journal Year:
2024,
Volume and Issue:
13(11), P. 1276 - 1276
Published: Oct. 23, 2024
Multiple
sclerosis
(MS)
is
a
chronic,
progressive
demyelinating
disease
with
most
likely
autoimmune
background
and
neurodegenerative
component.
Besides
the
process
caused
by
autoreactive
antibodies,
an
increased
permeability
in
blood-brain
barrier
(BBB)
also
plays
key
role.
Recently,
there
has
been
growing
interest
assessing
lipid
profile
alterations
patients
MS.
As
result
of
myelin
destruction,
increase
level
cholesterol
released
from
cells,
which
turn
causes
disruptions
metabolism
homeostasis
both
central
nervous
system
(CNS)
peripheral
tissues.
Currently,
body
evidence
suggesting
protective
role
HDL
MS
through
its
effect
on
BBB
decreasing
permeability.
This
follows
impact
endothelium
anti-inflammatory
effect,
mostly
interacting
adhesion
molecules
like
vascular
cell
molecule
1
(VCAM-1),
intercellular
(ICAM-1),
E-selectin.
HDL,
action
via
sphingosine-1-phosphate,
exerts
inhibitory
leukocyte
migration,
antioxidant
properties
contribute
to
improvement
function.
In
this
review,
we
want
summarize
these
studies
focus
as
mediator
response
Language: Английский
Centella asiatica Promotes Antioxidant Gene Expression and Mitochondrial Oxidative Respiration in Experimental Autoimmune Encephalomyelitis
Payel Kundu,
No information about this author
Kanon Yasuhara,
No information about this author
Mikah S. Brandes
No information about this author
et al.
Pharmaceuticals,
Journal Year:
2024,
Volume and Issue:
17(12), P. 1681 - 1681
Published: Dec. 13, 2024
Background/Objectives:
Centella
asiatica
(L.)
Urban
(family
Apiaceae)
(C.
asiatica)
is
a
traditional
botanical
medicine
used
in
aging
and
dementia.
Water
extracts
of
C.
(CAW)
have
been
to
treat
neuropsychiatric
symptoms
related
animal
models
are
associated
with
increases
antioxidant
response
element
(ARE)
genes
improvements
mitochondrial
respiratory
function
neuronal
health.
Because
multiple
sclerosis
(MS)
shares
its
neurogenerative
pathology
oxidative
stress
dysfunction
dementia,
MS
may
also
benefit
from
asiatica.
To
determine
whether
CAW
similarly
benefits
symptoms,
ARE
gene
expression,
respiration
inflammatory
MS,
the
effects
on
clinical
disability
inflammation,
we
tested
using
experimental
autoimmune
encephalomyelitis
(EAE).
Methods:
C57BL/6J
mice
induced
EAE
were
treated
or
placebo
for
2
weeks.
The
outcomes
disability,
signs
anxiety
(open
field
test),
respiration,
inflammation
demyelination.
Results:
At
dosing
schedule
concentrations
tested,
CAW-treated
demonstrated
increased
expression
activity
compared
those
placebo-treated
EAE.
was
reduced
infiltrates
spinal
cord,
but
differences
between
populations
activated
versus
quiescent
microglia
equivocal.
did
not
improve
behavioral
performance,
motor
Conclusions:
In
model
demonstrates
similar
neuroprotective
it
exhibits
dementia
mouse
models.
These
benefits,
along
anti-inflammatory
CAW,
support
further
investigation
people
MS.
Language: Английский